This website uses cookies to help us give you the best browsing experience. By continuing to use this portal, you agree to our use of this tool.
To learn more about how we use cookies and how to manage them please read our notice here.
Tip of the Month
Tip of the month - Per-operative use of anti-VEGF agents improves the chance of success of trabeculectomy
Per-operative use of anti-VEGF agents improves the chance of success of trabeculectomy

Publishing date: October 2014

The Science behind the Tip

Anti-VEGF agents have been widely used in a variety of ocular diseases for their activity in decreasing blood vessel formation. In glaucoma surgery, these drugs' anti-angiogenic and anti-fibrotic properties have been suggested to play a role in inhibiting bleb vascularization and decreasing postoperative scarring (1).

While research on the most suitable compound and its optimal route of administration are ongoing, the cumulative data from small-scale studies from several centers suggest inhibiting VEGF activity to be an attractive pathway in modulating wound healing in glaucoma surgery (2,3).

A prospective, randomized surgical trial in open-angle glaucoma patients has recently suggested that a single intracameral injection of bevacizumab (1.25mg/50µL) during trabeculectomy increases significantly the chances of success at 12 months (4).

Contributors: Luís Abegão Pinto and Ingeborg Stalmans


1. Mathew R, Barton K. Anti-vascular endothelial growth factor therapy in glaucoma filtration surgery. Am J Ophthalmol 2011;152(1):10-5.e2.

2. Grewal DS, Jain R, Kumar H, Grewal SP. Evaluation of subconjunctival bevacizumab as an adjunct to trabeculectomy a pilot study. Ophthalmology 2008;115(12):2141-5.e2.

3. Kahook MY. Bleb morphology and vascularity after trabeculectomy with intravitreal ranibizumab: a pilot study. Am J Ophthalmol 2010;150(3):399-403.e1.

4. Vandewalle E, Abegão Pinto L, Van Bergen T, et al. Intracameral bevacizumab as an adjunct to trabeculectomy: a 1-year prospective, randomised study. Br J Ophthalmol 2014;98(1):73-8.

Tip Reviewer: Roger Hitchings
Tip Editors: John Salmon and Gordana Sunaric Mégevand

back to top